NYSE •
Healthcare •
Medical Devices •
Quote as of 09/08/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization5.2 mln
Float11.46 mln
Earnings Date09/30/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-5.93
Highly reliable
Relative Strength
60
/ 100
Outperforming
Debt / Equity
-0.05
Negative equity
Pre-Tax Margin
-2,394%
Severely loss-making
ROE
-1,163
Deeply negative
Business Description
Founded in 2017 and headquartered in Singapore, Phaos Technology Holdings develops and sells a range of advanced microscopy products and software for industrial, biomedical, and research applications. Its product lineup includes tools for high-resolution imaging, dimensional measurement, failure analysis, quality control, and three-dimensional sample visualization. The company's customers include manufacturers, biomedical service providers, and research institutions.
